Heparanase Regulates Thrombosis in Vascular Injury and Stent-Induced Flow Disturbance

Abstract

Objectives The purpose of this study was to examine the role of heparanase in controlling thrombosis following vascular injury or endovascular stenting. Background The use of endovascular stents are a common clinical intervention for the treatment of arteries occluded due to vascular disease. Both heparin and heparan sulfate are known to be potent inhibitors of thrombosis. Heparanase is the major enzyme that degrades heparan sulfate in mammalian cells. This study examined the role of heparanase in controlling thrombosis following vascular injury and stent-induced flow disturbance. Methods This study used mice overexpressing human heparanase and examined the time to thrombosis using a laser-induced arterial thrombosis model in combination with vascular injury. An ex vivo system was used to examine the formation of thrombus to stent-induced flow disturbance. Results In the absence of vascular injury, wild type and heparanase overexpressing (HPA Tg) mice had similar times to thrombosis in a laser-induced arterial thrombosis model. However, in the presence of vascular injury, the time to thrombosis was dramatically reduced in HPA Tg mice. An ex vivo system was used to flow blood from wild type and HPA Tg mice over stents and stented arterial segments from both animal types. These studies demonstrate markedly increased thromboses on stents with blood isolated from HPA Tg mice in comparison to blood from wild type animals. We found that blood from HPA Tg animals had markedly increased thrombosis when applied to stented arterial segments from either wild type or HPA Tg mice. Conclusions Taken together, this study’s results indicate that heparanase is a powerful mediator of thrombosis in the context of vascular injury and stent-induced flow disturbance.

The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice

“…Moreover, transgenic mice overexpressing human heparanase exhibited shortened time to arterial thrombosis following vascular injury and increased in-stent thrombosis. 78 Importantly and strongly suggesting a causal role for heparanase overexpression in senescent endothelial cells for venous thrombosis, we now show that the prothrombotic phenotype of aged mice can be reversed by perioperative TFPI2 peptide administration and inhibition of heparanase procoagulant activity. 22 From a translational viewpoint, targeting endothelial heparanase to prevent age-associated enhanced coagulation might represent a 'safer' and more specific alternative to p53 inhibitors.…”

Loss of Syndecan-1 Induces a Pro-inflammatory Phenotype in Endothelial Cells with a Dysregulated Response to Atheroprotective Flow

“…In addition, sdc-1 is a target for heparanase activity and leads to shedding from the cell surface (52). Our group has recently identified a key role for the enzyme heparanase in restenosis and thrombosis in vascular injury (53,54). We also found increased heparanase expression in severe atherosclerotic plaques and in arterial segments of the coronary vessels with low shear stress in a diabetic, hyperlipidemic porcine model of atherosclerosis (27).…”

A Combination Therapy of Nicotinamide and Progesterone Improves Functional Recovery following Traumatic Brain Injury

“…62 Jullienne and colleagues 63 hypothesized that the long-term changes in cognitive dysfunction after TBI is due to changes in vasulcar dysfunction, along with changes at the blood brain barrier altering amyloid-beta clearance. Therefore, the effect of the combination treatment on blood vessel development may be responsible for the improvement in the recovery of function over the single treatments alone.…”